Publications by authors named "Diane Warren"

Claim this Profile
P
Phase 1 open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma.
Jacob P Laubach, Sascha A Tuchman, Jacalyn M Rosenblatt, Constantine S Mitsiades, Kathleen Colson, Diane Warren

Blood Cancer J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.
Irene M Ghobrial, Chia-Jen Liu, Oksana Zavidij, Abdel K Azab, Rachid Baz, Diane Warren

Am J Hematol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.
Guangwu Guo, Noopur S Raje, Charles Seifer, Jake Kloeber, Randi Isenhart, Diane Warren

Leukemia· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Paul G Richardson, Marcie L Riches, Nancy A Kernan, Joel A Brochstein, Shin Mineishi, Diane Warren

Blood· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
Cindy Varga, Wanling Xie, Jacob Laubach, Irene M Ghobrial, Elizabeth K O'Donnell, Diane Warren

Br J Haematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib in previously treated Waldenström's macroglobulinemia.
Steven P Treon, Christina K Tripsas, Kirsten Meid, Diane Warren, Gaurav Varma

N Engl J Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia.
Steven P Treon, Christina K Tripsas, Kirsten Meid, Sandra Kanan, Patricia Sheehy, Diane Warren

Blood· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma.
Paul G Richardson, Wanling Xie, Sundar Jagannath, Andrzej Jakubowiak, Sagar Lonial, Diane Warren

Blood· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational study.
Rachel Rosovsky, Fangxin Hong, Deanna Tocco, Brendan Connell, Constantine Mitsiades, Diane Warren

Br J Haematol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia.
Irene M Ghobrial, Federico Campigotto, Timothy J Murphy, Erica N Boswell, Ranjit Banwait, Diane Warren

Blood· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib.
Paul G Richardson, Jacob P Laubach, Robert L Schlossman, Irene M Ghobrial, Katherine C Redman, Diane Warren

Eur J Haematol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a protocol for the prevention and management of extravasation injuries in the neonatal intensive care patient.
Diane Warren

Int J Evid Based Healthc· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study.
Irene M Ghobrial, Edie Weller, Ravi Vij, Nikhil C Munshi, Ranjit Banwait, Diane Warren

Lancet Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.
Irene M Ghobrial, Wanling Xie, Swaminathan Padmanabhan, Ashraf Badros, Meghan Rourke, Diane Warren

Am J Hematol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.
Paul G Richardson, Edie Weller, Sagar Lonial, Andrzej J Jakubowiak, Sundar Jagannath, Diane L Warren

Blood· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.
Paul G Richardson, Robert J Soiffer, Joseph H Antin, Hajime Uno, Zhezhen Jin, Diane Warren

Biol Blood Marrow Transplant· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia.
Irene M Ghobrial, Fangxin Hong, Swaminathan Padmanabhan, Ashraf Badros, Meghan Rourke, Diane Warren

J Clin Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring treatment for multiple myeloma patients with relapsed and refractory disease.
Paul G Richardson, Jacob Laubach, Constantine Mitsiades, Robert L Schlossman, Deborah Doss, Diane L Warren

Oncology (Williston Park)· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia.
Irene M Ghobrial, Aldo Roccaro, Fangxin Hong, Edie Weller, Nancy Rubin, Diane Warren

Clin Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, phase I, dose-escalation trial of lenalidomide plus bortezomib for relapsed and relapsed/refractory multiple myeloma.
Paul G Richardson, Edie Weller, Sundar Jagannath, David E Avigan, Melissa Alsina, Diane L Warren

J Clin Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
Corey Cutler, Kristen Stevenson, Haesook T Kim, Paul Richardson, Vincent T Ho, Diane Warren

Blood· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.
Kevin R Viel, Deepa K Machiah, Diane M Warren, Manana Khachidze, Alfonso Buil, Stephen T Warren

Blood· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma.
Paul G Richardson, Emily Blood, Constantine S Mitsiades, Sundar Jagannath, Steven R Zeldenrust, Diane Warren

Blood· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heritability and linkage analysis of hand, foot, and eye preference in Mexican Americans.
Diane M Warren, Michael Stern, Ravindranath Duggirala, Thomas D Dyer, Laura Almasy

Laterality· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linkage disequilibrium across two different single-nucleotide polymorphism genome scans.
Juan Manuel Peralta, Thomas D Dyer, Diane M Warren, John Blangero, Laura Almasy

BMC Genet· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis